These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19237809)

  • 21. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa.
    Delanaye P; Cavalier E; Radermecker RP; Paquot N; Depas G; Chapelle JP; Scheen AJ; Krzesinski JM
    Nephron Clin Pract; 2008; 110(3):c158-63. PubMed ID: 18953178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cystatin C is a better marker of topotecan clearance than serum creatinine.
    Hoppe A; Séronie-Vivien S; Thomas F; Delord JP; Malard L; Canal P; Chatelut E
    Clin Cancer Res; 2005 Apr; 11(8):3038-44. PubMed ID: 15837759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is cystatin C a better marker than creatinine for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis?
    Yang Q; Li R; Zhong Z; Mao H; Fan J; Lin J; Yang X; Wang X; Li Z; Yu X
    Nephrol Dial Transplant; 2011 Oct; 26(10):3358-65. PubMed ID: 21367849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
    del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
    Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
    Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
    Malik AR; Little MA; Henriksson M; Tam FW; Brown EA
    J Nephrol; 2007; 20(3):340-9. PubMed ID: 17557268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S; Iliescu EA; Morton AR
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
    Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can the creatinine dialysate-to-plasma ratio from the peritoneal equilibration test be replaced by the sodium dialysate-to-plasma ratio and the sodium level in the dialysate?
    García R; Miguel A; Oviedo M; Martínez A; Esteve S; Pérez-Contreras J
    Adv Perit Dial; 2000; 16():19-21. PubMed ID: 11045254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
    Lin JJ; Wadhwa NK; Suh H; Cabralda T; Patlak CS
    Adv Perit Dial; 1995; 11():63-6. PubMed ID: 8534740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis.
    Beringer PM; Hidayat L; Heed A; Zheng L; Owens H; Benitez D; Rao AP
    J Cyst Fibros; 2009 Jan; 8(1):19-25. PubMed ID: 18799365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of clinical variables and immunosuppression on serum cystatin C and beta-trace protein in kidney transplant recipients.
    White CA; Akbari A; Doucette S; Fergusson D; Ramsay T; Hussain N; Dinh L; Filler G; Lepage N; Knoll GA
    Am J Kidney Dis; 2009 Nov; 54(5):922-30. PubMed ID: 19619919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystatin C a marker for renal function after exercise.
    Mingels A; Jacobs L; Kleijnen V; Wodzig W; Dieijen-Visser Mv
    Int J Sports Med; 2009 Sep; 30(9):668-71. PubMed ID: 19544228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between bone morphogenic protein-7 and peritoneal transport characteristics.
    Szeto CC; Chow KM; Kwan BC; Lai KB; Chung KY; Leung CB; Li PK
    Nephrol Dial Transplant; 2008 Sep; 23(9):2989-94. PubMed ID: 18400816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome.
    Barakat M; Khalil M
    Arab J Gastroenterol; 2011 Sep; 12(3):131-5. PubMed ID: 22055590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
    Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
    Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short peritoneal equilibration test: impact of preceding dwell time.
    Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
    Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.